Patents by Inventor Robert Wallin

Robert Wallin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075815
    Abstract: A refuse vehicle includes a chassis, an energy storage device supported by the chassis and configured to provide electrical power to a prime mover, wherein activation of the prime mover selectively drives the refuse vehicle, a body for storing refuse therein supported by the chassis, a first hydraulic pump configured to convert electrical power into hydraulic power, a second first hydraulic pump configured to convert electrical power into hydraulic power, and a motor coupled to at least one of the body or the chassis and configured to drive the first hydraulic pump and drive the second hydraulic pump.
    Type: Application
    Filed: August 30, 2023
    Publication date: March 7, 2024
    Inventors: Jeffrey Koga, Emily Davis, Jerrod Kappers, Vince Schad, Robert S. Messina, Christopher K. Yakes, Vincent Hoover, Clinton T. Weckwerth, Zachary L. Klein, John Beck, Brendan Chan, Skylar A. Wachter, Nader Nasr, Chad K. Smith, Logan Gary, Derek A. Wente, Shawn Naglik, Mike J. Bolton, Jacob Wallin, Quincy Wittman, Christopher J. Rukas, Dylan Hess, Jason Rice, Zhenyi Wei, Bashar Amin, Catherine Linsmeier, Joshua D. Rocholl, Dale Matsumoto
  • Publication number: 20240033320
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: December 14, 2022
    Publication date: February 1, 2024
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Publication number: 20230118205
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Application
    Filed: August 16, 2022
    Publication date: April 20, 2023
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Patent number: 11564969
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: January 31, 2023
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (publ)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Patent number: 11434258
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: September 6, 2022
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Patent number: 11304990
    Abstract: The present invention provides a method of treating intracellular infections, in particular intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: April 19, 2022
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Patent number: 11059845
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in claim 1. The macrolides have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Patent number: 11059846
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Patent number: 11059844
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in the claims. The macrolides have utility in treating viral diseases and cancer.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Patent number: 10919927
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating viral diseases and cancer.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: February 16, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Robert Wallin, Emma Lindh, Matt Gregory, Steven Moss
  • Publication number: 20200010498
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in the claims. The macrolides have utility in treating viral diseases and cancer.
    Type: Application
    Filed: February 22, 2018
    Publication date: January 9, 2020
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Publication number: 20200010499
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: February 22, 2018
    Publication date: January 9, 2020
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Publication number: 20190389896
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in claim 1. The macrolides have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: February 22, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Publication number: 20190388497
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Publication number: 20190389908
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Publication number: 20190374598
    Abstract: The present invention provides a method of treating intracellular infections, in particular intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 12, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Publication number: 20190367551
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating viral diseases and cancer.
    Type: Application
    Filed: February 22, 2018
    Publication date: December 5, 2019
    Inventors: Ola Winqvist, Robert Wallin, Emma Lindh, Matt Gregory, Steven Moss